Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.

Intrinsic low-level resistance to anti-cancer drugs is a major problem in the treatment of gastrointestinal malignancies. To address the problem presented by intrinsically resistant tumours, we have isolated two monoclonal lines from LoVo human colon adenocarcinoma cells: LoVo/C7, which is intrinsic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolfini, E., Dasdia, T., Arancia, G., Molinari, A., Calcabrini, A., Scheper, R. J., Flens, M. J., Gariboldi, M. B., Monti, E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223778/
https://www.ncbi.nlm.nih.gov/pubmed/9218735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223778/
https://www.ncbi.nlm.nih.gov/pubmed/9218735

Ejemplares similares